Literature DB >> 15954867

Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*.

Ian Tummon1, Larisa Gavrilova-Jordan, Michael C Allemand, Donna Session.   

Abstract

OBJECTIVES: To assess and quantify the relationship between polycystic ovaries (PCOs) and ovarian hyperstimulation syndrome (OHSS). DATA SOURCES: Published studies, any language, identified through MEDLINE, EMBASE, BIOSIS, Web of Science, and bibliographies. Studies were selected if exposure (ultrasound findings of PCO before treatment) and outcome (OHSS) could be abstracted to two-by-two tables.
RESULTS: Ten studies, meeting inclusion and exclusion criteria, were analyzed. When PCO were present, the combined odds ratio for OHSS was 6.8 (95% confidence interval 4.9-9.6).
CONCLUSION: There is a significant and consistent relationship between PCO and OHSS. When PCO are present before treatment with assisted reproduction, deliberate policies to moderate treatment appear justified.

Entities:  

Mesh:

Year:  2005        PMID: 15954867     DOI: 10.1111/j.0001-6349.2005.00788.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  18 in total

1.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

2.  Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

Authors:  Marla E Lujan; Eric D Brooks; Anna L Kepley; Donna R Chizen; Roger A Pierson; Andrew K Peppin
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

3.  Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.

Authors:  David A Schirmer; Aniket D Kulkarni; Yujia Zhang; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2020-07-14       Impact factor: 7.329

4.  Increased incidence of post-term delivery and Cesarean section after frozen-thawed embryo transfer during a hormone replacement cycle.

Authors:  Kazuki Saito; Kenji Miyado; Kenji Yamatoya; Akira Kuwahara; Eisuke Inoue; Mami Miyado; Maki Fukami; Tomonori Ishikawa; Takakazu Saito; Toshiro Kubota; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

Review 5.  Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

6.  Recombinant follicle-stimulating hormone (follitropin alfa) for ovulation induction in Japanese patients with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a phase II dose-response study.

Authors:  Yuji Taketani; Eduardo Kelly; Yasunori Yoshimura; Hiroshi Hoshiai; Minoru Irahara; Hideki Mizunuma; Hidekazu Saito; Kazumichi Andoh; Zourab Bebia; Takumi Yanaihara
Journal:  Reprod Med Biol       Date:  2009-12-23

7.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

8.  Recombinant follicle-stimulating hormone (follitropin alfa) versus purified urinary follicle-stimulating hormone in a low-dose step-up regimen to induce ovulation in Japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a single-blind Phase III study.

Authors:  Yuji Taketani; Eduardo Kelly; Yasunori Yoshimura; Hiroshi Hoshiai; Minoru Irahara; Hideki Mizunuma; Hidekazu Saito; Kazumichi Andoh; Takumi Yanaihara
Journal:  Reprod Med Biol       Date:  2010-02-23

Review 9.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Statins in the treatment of polycystic ovary syndrome.

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Semin Reprod Med       Date:  2008-01       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.